CENTENNIAL, Colo., May 25, 2023 /PRNewswire/ — AlloSource®, one of the largest nonprofit allograft providers in the U.S. creating innovative cellular and tissue products to help surgeons heal their patients, today announced the launch of AlloMend® Duo Acellular Dermal Matrix (ADM), a…
Related Articles
News
Women Are at a Higher Risk of Dying From Heart Disease − in Part Because Doctors Don’t Take Major Sex and Gender Differences Into Account
October 29, 2024
UCBN
News, Syndication
Comments Off on Women Are at a Higher Risk of Dying From Heart Disease − in Part Because Doctors Don’t Take Major Sex and Gender Differences Into Account
A simple difference in the genetic code – two X chromosomes versus one X chromosome and one Y chromosome – can lead to major differences in heart disease. It turns out that these genetic differences […]
News
Lewis Capaldi’s Tourette’s Diagnosis Shines Light on the Disorder
July 17, 2023
UCBN
News, Syndication
Comments Off on Lewis Capaldi’s Tourette’s Diagnosis Shines Light on the Disorder
Last month, Scottish singer and songwriter Lewis Capaldi announced an indefinite break from touring to focus on his health following a Glastonbury Festival performance where his fans joined in when his Tourette’s symptoms took over. […]
News
Feds begin audit that could lead to end of sanctions on Denver health company
November 10, 2022
UCBN
News
Comments Off on Feds begin audit that could lead to end of sanctions on Denver health company
Colorado has not begun a similar and needed audit, however, leading to uncertainty on the time frame for sanctions possibly being lifted. Click here to view original post
